Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Drug discovery collaboration established by Aurora and Merck

Jan. 7, 1998

CIMA terminates one and initiates another OraSolv agreement

Jan. 2, 1998

Genetronics develops new transdermal delivery method suitable for large molecules and genes

Dec. 30, 1997

Bayer/Genzyme drug discovery collaboration

Dec. 24, 1997

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

Dec. 22, 1997

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

LifeCell's ThromboSol to enter clinical feasibility study

Dec. 17, 1997

Orally activated protein therapy reported

Dec. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...